Neutrophil-to-Lymphocyte Ratio Predicts Prognosis in Castration-Resistant Prostate Cancer Patients Who Received Cabazitaxel Chemotherapy

Figure 1

Kaplan–Meier curve for OS after CBZ according to the NLR. The median OS in patients with the NLR < 3.83 and NLR ≥ 3.83 were 13.2 months and 5.8 months.